Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect and Safety of Electroconvulsive Therapy Plus Usual Care for the Acute Management of Severe Agitation in Dementia

NCT03926520 is registered in ClinicalTrials.gov with Brent Forester as lead sponsor.

NCT NCT03926520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03926520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect and Safety of Electroconvulsive Therapy Plus Usual Care for the Acute Management of Severe Agitation in Dementia
Lead sponsor
Brent Forester
Phase
Not applicable
Overall status
Completed
Start date
January 28, 2021
Completion date
May 31, 2026
Enrollment
41 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

agitation,psychomotor, alzheimer dementia